A positive correlation between FGFR1 expression and resistance to lapatinib was observed not only in BC cell lines (Fig. 4l and Extended Data Fig. 9e) but also for the entire PanCancer dataset (Extended Data Fig. 9f). The gene discussed is FGFR1; the disease is breast cancer.